De novo Drug Design using Reinforcement Learning with Multiple GPT Agents
De novo drug design is a pivotal issue in pharmacology and a new area of focus in AI for science research. A central challenge in this field is to generate molecules with specific properties while also producing a wide range of diverse candidates. Although advanced technologies such as transformer models and reinforcement learning have been applied in drug design, their potential has not been fully realized. Therefore, we propose MolRL-MGPT, a reinforcement learning algorithm with multiple GPT agents for drug molecular generation. To promote molecular diversity, we encourage the agents to collaborate in searching for desirable molecules in diverse directions. Our algorithm has shown promising results on the GuacaMol benchmark and exhibits efficacy in designing inhibitors against SARS-CoV-2 protein targets. The codes are available at: https://github.com/HXYfighter/MolRL-MGPT.
Code (2)
Tasks
DiversityDrug Designreinforcement-learningReinforcement LearningMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Utilizing Reinforcement Learning for de novo Drug Design
Deep learning-based approaches for generating novel drug molecules with specific properties have gained a lot of interest in the last few years. Recent studies have demonstrated promising performance for string-based gen…
DiversityDrug Designreinforcement-learningReinforcement LearningReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design
De novo drug design is a crucial component of modern drug development, yet navigating the vast chemical space to find synthetically accessible, high-affinity candidates remains a significant challenge. Reinforcement Lear…
Representation LearningReinforcement LearningWidely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model
De novo molecular design has facilitated the exploration of large chemical space to accelerate drug discovery. Structure-based de novo method can overcome the data scarcity of active ligands by incorporating drug-target …
Drug DesignDrug DiscoveryMolecular DockingReinforcement Learning (RL)Uncertainty-Aware Multi-Objective Reinforcement Learning-Guided Diffusion Models for 3D De Novo Molecular Design
Designing de novo 3D molecules with desirable properties remains a fundamental challenge in drug discovery and molecular engineering. While diffusion models have demonstrated remarkable capabilities in generating high-qu…
Reinforcement LearningDrug DiscoveryReinforcement Learning for Personalized Drug Discovery and Design for Complex Diseases: A Systems Pharmacology Perspective
Many multi-genic systemic diseases such as neurological disorders, inflammatory diseases, and the majority of cancers do not have effective treatments yet. Reinforcement learning powered systems pharmacology is a potenti…
Drug DesignDrug Discoveryreinforcement-learningReinforcement Learning+1